—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Yuhan Corp. (000100.KS) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for 000100.KS, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06

Company snapshot — Yuhan Corp.

000100.KS in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Yuhan is a South Korean pharmaceutical company that makes active pharmaceutical ingredients and intermediates for other drugmakers rather than selling many branded medicines of its own. It runs custom manufacturing, process research, and both small-batch and commercial-scale production of these ingredients, alongside analytical work and regulatory support for clients. Its output spans antibiotic, anti-thrombotic, anti-hyperlipidemic and anti-hypertensive compounds, plus custom synthesis for antiviral, HIV, HCV, antihistamine, antidiabetic and CNS-related intermediates. It is based in Seoul and also sells internationally.
Where it sits in the stack
Yuhan holds no seat in our index; it sits in the Healthcare sleeve of our universe, under specialty and generic drug manufacturing. Its work is pharmaceutical ingredient supply, not chip design, fabrication or any layer of the AI build-out.
Who it is priced against
The diary's peer group has no formal grouping for Yuhan; the closer market comparison is Hanmi Pharmaceutical, another Korean drugmaker with a similar mix of specialty and generic manufacturing.
Why Closelooknet tracks it
Yuhan carries no index seat, no quote in our editions and no Closelooknet score; it sits outside the coverage the diary has built out so far.
What the diary watches
The diary watches whether the recent pullback against the stock's longer-term average settles or extends before any coverage decision is made.

Yuhan Corp. (000100.KS) trades on the KO exchange in South Korea.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 0.79%, annual · last 600 KRW on 2026-02-26

Dividends and capital return

What 000100.KS pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 600 KRW per share · a 0.79% yield on the 2026-10-06 close 1 distribution, paid once a year 2026-10-06
  • Last distribution 600 KRW per share as the price series records it, within days of the ex-date 2026-02-26
  • By calendar year 2026: 600 KRW to date first distribution recorded in the three-year window: 2026-02-26

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Yuhan Corp. (000100.KS)?

Yuhan Corp. trades as 000100.KS on the KO exchange (South Korea) in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is 000100.KS in a Closelooknet index?

Not currently — Yuhan Corp. is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

Where does 000100.KS trade against its moving averages?

Downtrend stack: Trades -2.7% vs the 50-day and -15.7% vs the 200-day average, 40.6% below the 52-week high and +17.4% off the 52-week low. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

What does Yuhan Corp. do?

Yuhan is a South Korean pharmaceutical company that makes active pharmaceutical ingredients and intermediates for other drugmakers rather than selling many branded medicines of its own. It runs custom manufacturing, process research, and both small-batch and commercial-scale production of these ingredients, alongside analytical work and regulatory support for clients. Its output spans antibiotic, anti-thrombotic, anti-hyperlipidemic and anti-hypertensive compounds, plus custom synthesis for antiviral, HIV, HCV, antihistamine, antidiabetic and CNS-related intermediates. The diary's peer group has no formal grouping for Yuhan; the closer market comparison is Hanmi Pharmaceutical, another Korean drugmaker with a similar mix of specialty and generic manufacturing.

Where does Yuhan Corp. sit in the AI build-out?

Yuhan holds no seat in our index; it sits in the Healthcare sleeve of our universe, under specialty and generic drug manufacturing. Its work is pharmaceutical ingredient supply, not chip design, fabrication or any layer of the AI build-out. Yuhan carries no index seat, no quote in our editions and no Closelooknet score; it sits outside the coverage the diary has built out so far.

Does Yuhan Corp. pay a dividend?

Yuhan Corp. has paid 600 KRW per share over the last twelve months, paid once a year, a trailing yield of 0.79% on the 2026-10-06 close; the last distribution recorded in the price series was 600 KRW on 2026-02-26. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for 000100.KS, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.